Therapy delivery for identified tachyarrhythmia episode types

• US 7,941,208 B2
• Filed: 03/07/2007
• Issued: 05/10/2011
• Est. Priority Date: 11/29/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Cazares, Shelley Marie, Sauer, William H., Li, Dan
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Bays; Pamela M
• Application Number:
  US11/715,128
• Publication Number:
  US 20080125824A1
• Time in Patent Office: 1,525 Days
• Field of Search: 600/508, 600/509, 600515-518, 606/41, 606/42, 607/14, 607/27
• US Class Current: 600/518
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

Methods and systems for identifying tachyarrhythmia episode types and delivering therapy to mitigate the identified tachyarrhythmia episode types are described. Electrogram signals of cardiac activity are sensed and stored by an implantable cardiac device. Tachyarrhythmia episodes are detected and tachyarrhythmia episode types are identified based on characteristics of the electrogram signals. In preparation for performing ablation, a tachyarrhythmia episode is induced. The features of the induced tachyarrhythmia episode are compared to characteristics of the identified episode types. A similarity between the induced tachyarrhythmia episode and at least one of the episode types identified from the stored electrogram signals is indicated to facilitate performing the ablation.

Claims

1. A method of operating a cardiac system that includes an implantable cardiac device that is implanted in a patient, the implantable cardiac device including implantable electrodes adapted to be positioned at respective specific sites within the patient, the method comprising:

for a first period of time;

sensing and storing electrogram signals of cardiac electrical activity from the patient in the implantable cardiac device, the sensing being carried out using the implantable electrodes;

detecting first intrinsic tachyarrhythmia episodes using the electrogram signals; and

identifying first tachyarrhythmia episode morphology types based on morphological characteristics of the electrogram signals for the detected first intrinsic tachyarrhythmia episodes; and

after the first period of time, in preparation for performing ablation;

inducing a tachyarrhythmia episode;

sensing electrogram signals from the induced tachyarrhythmia episode using the implantable electrodes;

using the sensed electrogram signals from the induced tachyarrhythmia episode to compare morphological characteristics of the induced tachyarrhythmia episode to the morphological characteristics of the detected first intrinsic tachyarrhythmia episodes; and

indicating a similarity between the induced tachyarrhythmia episode and at least one of the first tachyarrhythmia episode morphology types identified from the stored electrogram signals to facilitate performing the ablation;

wherein the method further comprises;

for each identified first tachyarrhythmia episode morphology type, determining how many of the detected first intrinsic tachyarrhythmia episodes exhibited that identified episode morphology type; and

for each identified first tachyarrhythmia episode morphology type, displaying a number of how many first intrinsic tachyarrhythmia episodes were detected for that identified episode morphology type.

2. The method of claim 1, further comprising ranking the episode types based on the number of detected first intrinsic tachyarrhythmia episodes determined for each identified episode type, a rank of an episode type corresponding to a tachyarrhythmia burden of the episode type.

3. The method of claim 1, further comprising performing the ablation in such a way as to prevent future occurrences of one or more of the identified episode types.

4. The method of claim 1, further comprising:

for a second period of time after performing the ablation;

sensing and storing second electrogram signals of cardiac electrical activity from the patient in the implantable cardiac device;

detecting second intrinsic tachyarrhythmia episodes using the second electrogram signals; and

identifying second tachyarrhythmia episode morphology types based on characteristics of the second electrogram signals; and

comparing the first tachyarrhythmia episode morphology types identified from the first intrinsic tachyarrhythmia episodes stored before ablation to the second tachyarrhythmia episode morphology types identified from the second intrinsic tachyarrhythmia episodes stored after ablation.

5. The method of claim 1, wherein the characteristics of the first intrinsic tachyarrhythmia episodes of each first tachyarrhythmia episode morphology type are associated with a conduction pattern of the episode morphology type.

6. The method of claim 1, further comprising ranking the tachyarrhythmia episode morphology types, wherein the criteria used for the ranking is user programmable.

7. The method of claim 1, wherein determining comprises:

identifying, by a user, one or more episodes defining boundary episodes between the episode morphology types; and

grouping the first intrinsic tachyarrhythmia episodes based on the boundary episodes.

8. The method of claim 1, wherein the determining is carried out by a user.

9. The method of claim 1, wherein the determining is carried out algorithmically.

10. The method of claim 1, wherein:

sensing the electrogram signals comprises sensing a far field electrogram signal using a far field sensing vector and a near field electrogram signal using a near field sensing vector.

11. The method of claim 1, wherein:

sensing the electrogram signals comprises sensing a plurality of near field electrogram signals and a plurality of far field electrogram signals.

12. The method of claim 1, further comprising determining exit sites of the identified first tachyarrhythmis episode morphology types using the electrogram signals.

13. A cardiac system , comprising:

an implantable sensing system configured to sense and store electrogram signals from a patient , the electrogram signals obtained using implantable electrodes adapted to be positioned at respective specific sites within the patient;

an implantable tachyarrhythmia detector configured to detect first intrinsic tachyarrhythmia episodes using the electrogram signals and to determine morphological characteristics of the detected first intrinsic tachyarrhythmia episodes from the electrogram signals, the detector further configured to detect, using the implantable electrodes, a tachyarrhythmia episode induced in preparation for performing ablation;

a data processor configured to;

identify episode morphology types that historically have been experienced by the patient based on the morphological characteristics of the detected first intrinsic tachyarrhythmia episodes;

determine how many of the detected first intrinsic tachyarrhythmia episodes are associated with each identified episode morphology type; and

determine a similarity between the induced tachyarrhythmia episode and at least one of the identified episode morphology types; and

a display configured to;

display a number of how many detected first intrinsic tachyarrhythmia episodes are counted for each identified episode morphology type; and

present information related to the similarity between the induced tachyarrhythmia episode and the at least one identified episode morphology type to facilitate performing the ablation.

14. The system of claim 13, wherein the data processor is configured to rank the episode morphology types, a rank of an episode morphology type corresponding to a tachyarrhythmia burden of the episode morphology type.

15. The system of claim 13, wherein the data processor is configured to rank each episode morphology type based on the number of tachyarrhythmia episodes counted for each identified episode morphology type.

16. The system of claim 13, wherein the data processor is configured to discriminate a first type of ventricular tachyarrhythmia episode from a second type of ventricular tachyarrhythmia episode.

17. The system of claim 13, wherein:

the implantable electrodes comprise;

a first pair of cardiac electrodes configured to sense a far field electrogram signal; and

a second pair of cardiac electrodes configured to sense a near field electrogram signal; and

the tachyarrhythmia detector is configured to determine the morphological characteristics of the first intrinsic tachyarrhythmia episodes using the far field electrogram signal and the near field electrogram signal.

18. The system of claim 13, wherein:

the implantable electrodes comprise;

a plurality of far field cardiac electrode pairs, each far field electrode pair configured to sense a far field electrogram signal; and

a plurality of near field cardiac electrode pairs, each near field electrode pair configured to sense a near field electrogram signal; and

the tachyarrhythmia detector is configured to determine the morphological characteristics of the first intrinsic tachyarrhythmia episodes using at least one of the plurality of far field electrogram signals and at least one of the plurality of near field electrogram signals.

19. The system of claim 13, wherein the data processor is further configured to determine an exit site of one or more of the identified episode morphology types based on the electrogram signals.

20. The system of claim 13, wherein the data processor is further configured to compare characteristics of the first intrinsic tachyarrhythmia episodes to electrogram signals of paced beats to determine an exit site of one or more identified episode morphology types.

21. A system, comprising:

an implantable sensing system configured to sense electrogram signals from a patient using implantable electrodes adapted to be positioned at respective specific sites within the patient;

an implantable tachyarrhythmia detector configured to detect first intrinsic tachyarrhythmia episodes using the electrogram signals and to determine morphological characteristics of the first intrinsic tachyarrhythmia episodes from the electrogram signals;

means for identifying episode morphology types based on the morphological characteristics of the first intrinsic tachyarrhythmia episodes that have been detected in the patient over a first period of time;

means for determining a similarity between one or more of the identified episode morphology types and a tachyarrhythmia episode that is induced in the patient after the first period of time in preparation for performing ablation;

means for determining how many of the detected first intrinsic tachyarrhythmia episodes are associated with each identified episode morphology type; and

means for displaying a number of how many first intrinsic tachyarrhythmia episodes were detected for each identified episode morphology type.

22. The system of claim 21, further comprising means for determining an exit site for each identified episode morphology type based on the electrogram signals.